[Linezolid--new antibacterial agent of the oxazolidinone group: its importance in the control of spreading and treatment of the multidrug resistance gram-positive infections].
Budanov
S V
SV
Research Centre of Drug Evaluation, National Research Centre of Antibiotics, Moscow.
Smirnova
L B
LB
D000081:Acetamides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000472:pathogenicity / Q000502:physiology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000627:therapeutic use*; D013291:Streptococcus / Q000187:drug effects
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid